Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02445521 · ClinicalTrials.gov registry record
Testing of Four Home Phenylalanine Monitoring Prototype Devices
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 9
- Enrollment target
NCT02445521: Completed study, sponsored by Emory University.
NCT02445521 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02445521 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
The objective of this study is to test four home phenylalanine monitoring prototype devices, selected out of a pool of candidates by the National PKU Alliance Scientific Committee.
Primary Outcome
Phenylalanine values for each of the three runs on each device for the same individual will be compared. Each PKU subject will be assessed separately to assess the reliability of each device since the subjects will have a range of phenylalanine concentrations.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2015-05 |
| Est. Completion | 2015-05 |
What the finished NCT02445521 record still lists
NCT02445521 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02445521 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02445521 about?
NCT02445521 is a clinical study titled "Testing of Four Home Phenylalanine Monitoring Prototype Devices". The objective of this study is to test four home phenylalanine monitoring prototype devices, selected out of a pool of candidates by the National PKU Alliance Scientific Committee.
What is the current status of trial NCT02445521?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2015-05. Estimated completion is 2015-05.
Who is sponsoring clinical trial NCT02445521?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia